INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 442m ago
HOUSE PTR41m ago
SEC 13F41m ago
ROBINHOOD CHAIN41m ago
Corporate insider
HD

Hallett David

Chief Scientific OfficerCIK 0002006495

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells0 / 0
Max Insider Score12
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
HD
Hallett DavidChief Scientific Officer
RXRXRECURSION PHARMACEUTICALS, INC.
Tax withholding
F$84K
26.7K sh
Aug 17, 2026Aug 18, 2026
traded Aug 17, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    RECURSION PHARMACEUTICALS, INC.Chief Scientific Officer · May 19, 2026
12
HD
Hallett DavidChief Scientific Officer
RXRXRECURSION PHARMACEUTICALS, INC.
Tax withholding
F
$81K
26.7K sh
May 15, 2026
May 19, 2026
traded May 15, 2026
+4d
SEC FORM 4

Evidence